Shenling Guchang prescription ameliorates intestinal barrier inflammation in gestational diabetes rats via TLR4/NF-κB pathway.

MLA

Li, Manling, et al. “Shenling Guchang Prescription Ameliorates Intestinal Barrier Inflammation in Gestational Diabetes Rats via TLR4/NF-ΚB Pathway.” Drug Discoveries & Therapeutics, Dec. 2024. EBSCOhost, https://doi.org/10.5582/ddt.2024.01066.

APA

Li, M., Li, L., Liu, X., Yang, T., Gao, J., Wu, A., Hua, Z., & Wang, L. (2024). Shenling Guchang prescription ameliorates intestinal barrier inflammation in gestational diabetes rats via TLR4/NF-κB pathway. Drug Discoveries & Therapeutics. https://doi.org/10.5582/ddt.2024.01066

Chicago

Li, Manling, Lisha Li, Xingman Liu, Tao Yang, Jingyun Gao, Anqin Wu, Zhaozhao Hua, and Ling Wang. 2024. “Shenling Guchang Prescription Ameliorates Intestinal Barrier Inflammation in Gestational Diabetes Rats via TLR4/NF-ΚB Pathway.” Drug Discoveries & Therapeutics, December. doi:10.5582/ddt.2024.01066.